Paradigm co-founder: SBF once stated that Alameda did not receive preferential treatment at FTX

ChainCatcher news, according to The Block, Paradigm co-founder Matt Huang testified in court on Thursday regarding the SBF case, describing the process of Paradigm's two investments totaling approximately $278 million in FTX.

Matt Huang stated that the rapid growth of FTX's early market share excited him, but he was concerned about the lack of a formal governance structure or even a board at FTX. SBF had previously told him that Alameda Research did not receive preferential treatment at FTX.

Additionally, Matt Huang mentioned that Paradigm's investment in FTX has been written down to zero.